1. Home
  2. TYRA vs SNDA Comparison

TYRA vs SNDA Comparison

Compare TYRA & SNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tyra Biosciences Inc.

TYRA

Tyra Biosciences Inc.

HOLD

Current Price

$26.04

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Sonida Senior Living Inc.

SNDA

Sonida Senior Living Inc.

HOLD

Current Price

$39.36

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TYRA
SNDA
Founded
2018
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Hospital/Nursing Management
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.9B
IPO Year
2021
1997

Fundamental Metrics

Financial Performance
Metric
TYRA
SNDA
Price
$26.04
$39.36
Analyst Decision
Strong Buy
Buy
Analyst Count
11
4
Target Price
$47.50
$35.75
AVG Volume (30 Days)
630.1K
403.5K
Earning Date
05-06-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$381,141,000.00
Revenue This Year
N/A
$68.73
Revenue Next Year
N/A
$11.11
P/E Ratio
N/A
N/A
Revenue Growth
N/A
25.24
52 Week Low
$9.96
$24.01
52 Week High
$40.65
$44.39

Technical Indicators

Market Signals
Indicator
TYRA
SNDA
Relative Strength Index (RSI) 34.50 46.81
Support Level $24.77 $38.66
Resistance Level $32.82 $43.59
Average True Range (ATR) 1.75 1.57
MACD -0.67 -0.29
Stochastic Oscillator 7.53 18.03

Price Performance

Historical Comparison
TYRA
SNDA

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines for large opportunities in targeted oncology and genetically defined conditions, harnessing the power of Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are FGFR3, FGFR4/3, and FGFR1/2/3: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

About SNDA Sonida Senior Living Inc.

Sonida Senior Living Inc is an owner-operator of senior housing communities in the United States in terms of resident capacity. It provides senior living services to the elderly, including independent living, assisted living, Respite Care and Temporary Care Programs, Home Care Services, and memory care services. The company's objective is to provide value to residents by providing quality senior housing services at reasonable prices. The basic services offered by the company at its senior housing communities comprise meals, housekeeping, laundry, 24-hour staffing, transportation, social and recreational activities, and healthcare monitoring.

Share on Social Networks: